Devonian Health Group is trading at CA$7.36, up +9.04%, with no verified company-specific announcement dated October 29 explaining the live increase. - Health Canada pediatric-trial authorization was reported October 28, but no source connects it to the rise. - Broader U.S. indexes were lower, offering no explanation for the stock’s gain. - Trading volume and activity level were unavailable in the provided live-price context.